These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22426112)

  • 1. LYP inhibits T-cell activation when dissociated from CSK.
    Vang T; Liu WH; Delacroix L; Wu S; Vasile S; Dahl R; Yang L; Musumeci L; Francis D; Landskron J; Tasken K; Tremblay ML; Lie BA; Page R; Mustelin T; Rahmouni S; Rickert RC; Tautz L
    Nat Chem Biol; 2012 Mar; 8(5):437-46. PubMed ID: 22426112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling.
    de la Puerta ML; Trinidad AG; Rodríguez Mdel C; de Pereda JM; Sánchez Crespo M; Bayón Y; Alonso A
    PLoS One; 2013; 8(1):e54569. PubMed ID: 23359562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
    Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
    J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology: Csk keeps LYP on a leash.
    Zhong MC; Veillette A
    Nat Chem Biol; 2012 Apr; 8(5):412-3. PubMed ID: 22510660
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
    Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
    J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
    Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
    Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22.
    Wallis AM; Wallace EC; Hostager BS; Yi Z; Houtman JCD; Bishop GA
    Sci Rep; 2017 May; 7(1):2081. PubMed ID: 28522807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.
    Cloutier JF; Veillette A
    J Exp Med; 1999 Jan; 189(1):111-21. PubMed ID: 9874568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells.
    Wu DJ; Zhou W; Enouz S; Orrú V; Stanford SM; Maine CJ; Rapini N; Sawatzke K; Engel I; Fiorillo E; Sherman LA; Kronenberg M; Zehn D; Peterson E; Bottini N
    PLoS One; 2014; 9(2):e86677. PubMed ID: 24498279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.
    Brdicka T; Pavlistová D; Leo A; Bruyns E; Korínek V; Angelisová P; Scherer J; Shevchenko A; Hilgert I; Cerný J; Drbal K; Kuramitsu Y; Kornacker B; Horejsí V; Schraven B
    J Exp Med; 2000 May; 191(9):1591-604. PubMed ID: 10790433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
    Du J; Qiao Y; Sun L; Wang X
    Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling.
    Vang T; Abrahamsen H; Myklebust S; Horejsí V; Taskén K
    J Biol Chem; 2003 May; 278(20):17597-600. PubMed ID: 12665526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling.
    Yang S; Svensson MND; Harder NHO; Hsieh WC; Santelli E; Kiosses WB; Moresco JJ; Yates JR; King CC; Liu L; Stanford SM; Bottini N
    Sci Signal; 2020 Mar; 13(623):. PubMed ID: 32184287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
    Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
    J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.
    Arimura Y; Vang T; Tautz L; Williams S; Mustelin T
    Mol Immunol; 2008 Jun; 45(11):3074-84. PubMed ID: 18457880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation.
    Manjarrez-Orduño N; Marasco E; Chung SA; Katz MS; Kiridly JF; Simpfendorfer KR; Freudenberg J; Ballard DH; Nashi E; Hopkins TJ; Cunninghame Graham DS; Lee AT; Coenen MJ; Franke B; Swinkels DW; Graham RR; Kimberly RP; Gaffney PM; Vyse TJ; Behrens TW; Criswell LA; Diamond B; Gregersen PK
    Nat Genet; 2012 Nov; 44(11):1227-30. PubMed ID: 23042117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the
    Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM
    J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway.
    Park JE; Brand DD; Rosloniec EF; Yi AK; Stuart JM; Kang AH; Myers LK
    J Biol Chem; 2020 Feb; 295(8):2239-2247. PubMed ID: 31932281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts.
    Torgersen KM; Vang T; Abrahamsen H; Yaqub S; Horejsí V; Schraven B; Rolstad B; Mustelin T; Taskén K
    J Biol Chem; 2001 Aug; 276(31):29313-8. PubMed ID: 11390365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors.
    Davidson D; Zhong MC; Pandolfi PP; Bolland S; Xavier RJ; Seed B; Li X; Gu H; Veillette A
    Cell Rep; 2016 Dec; 17(10):2776-2788. PubMed ID: 27926878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.